FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

23814005: Guanethidine monosulfate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
39980014 Guanethidine monosulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
753379011 Guanethidine monosulfate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
13401000188110 guanéthidine monosulfate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
815441000172112 monosulfate de guanéthidine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Guanethidine monosulfate Is a Product containing guanethidine (medicinal product) false Inferred relationship Some
Guanethidine monosulfate Is a Vasodilator (substance) false Inferred relationship Some
Guanethidine monosulfate Is a Guanethidine (substance) false Inferred relationship Some
Guanethidine monosulfate Is a Hypotensive agent (substance) true Inferred relationship Some
Guanethidine monosulfate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Guanethidine (substance) true Inferred relationship Some
Guanethidine monosulfate Is a Substance with adrenergic neurone blocker mechanism of action (substance) true Inferred relationship Some
Guanethidine monosulfate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Adrenergic neurone blocker true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Guanethidine monosulfate [antihypertensive] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
monosulfate de guanéthidine 10 mg/1 mL, pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Guanethidine monosulfate [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Guanethidine monosulfate 3% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Guanethidine monosulfate 2% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Guanethidine monosulfate 1% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Guanethidine monosulfate 0.5% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Guanethidine monosulfate 0.25% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Product containing guanethidine monosulfate and hydrochlorothiazide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Guanethidine monosulfate+epinephrine 0.25%/0.05% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Guanethidine monosulfate+epinephrine 1%/0.5% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Guanethidine monosulfate+epinephrine 0.5%/0.1% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Adrenaline 2 mg/mL and guanethidine monosulfate 10 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Guanethidine monosulfate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some
Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some 1
Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Guanethidine monosulfate Inferred relationship Some 1
Guanethidine monosulfate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some 1
Guanethidine monosulfate 25 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Guanethidine monosulfate Inferred relationship Some 1
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Guanethidine monosulfate Inferred relationship Some 1
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Guanethidine monosulfate Inferred relationship Some 1
Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Guanethidine monosulfate Inferred relationship Some 1
Guanethidine monosulfate 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Guanethidine monosulfate Inferred relationship Some 1
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Guanethidine monosulfate Inferred relationship Some 1
Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Guanethidine monosulfate Inferred relationship Some 2
Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Guanethidine monosulfate Inferred relationship Some 2
Adrenaline 2 mg/mL and guanethidine monosulfate 10 mg/mL eye drops The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Guanethidine monosulfate Inferred relationship Some 1
Adrenaline 2 mg/mL and guanethidine monosulfate 10 mg/mL eye drops This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Guanethidine monosulfate Inferred relationship Some 1
Product containing precisely guanethidine monosulfate 10 milligram/1 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Guanethidine monosulfate Inferred relationship Some 1
Product containing precisely guanethidine monosulfate 10 milligram/1 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Guanethidine monosulfate Inferred relationship Some 1
Product containing precisely guanethidine monosulfate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Guanethidine monosulfate Inferred relationship Some 1
Product containing precisely guanethidine monosulfate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Guanethidine monosulfate Inferred relationship Some 1
Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Guanethidine monosulfate Inferred relationship Some 1
Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Guanethidine monosulfate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start